WST: West Pharmaceutical Services, Inc.
About
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Current Value
$302.101 Year Return
Current Value
$302.101 Year Return
Key Details
Market Cap
$22.02B
P/E Ratio
45.11
1Y Stock Return
-13.73%
1Y Revenue Growth
-1.70%
Dividend Yield
0.22%
Price to Book
8.0
Strategies that include WST
Stock's related to WST
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| EW | 39.05% | $41.40B | +4.84% | 0.00% |
| STVN | 35.72% | $4.95B | -32.48% | 0.32% |
| ITGR | 35.26% | $4.48B | +49.37% | 0.00% |
| AUPH | 35.23% | $1.16B | -6.98% | 0.00% |
| ADT | 34.09% | $6.85B | +26.68% | 2.64% |
| RHI | 33.79% | $7.36B | -12.61% | 2.89% |
| WEX | 32.96% | $7.10B | +2.88% | 0.00% |
| WHR | 32.64% | $6.05B | +0.98% | 6.44% |
| RGEN | 32.47% | $7.20B | -18.16% | 0.00% |
| ASGN | 32.40% | $3.73B | -6.20% | 0.00% |
| QS | 32.28% | $2.54B | -13.31% | 0.00% |
| GBX | 31.03% | $2.03B | +73.41% | 1.86% |
| ALGN | 30.51% | $16.62B | +3.38% | 0.00% |
| RBBN | 30.41% | $678.74M | +86.06% | 0.00% |
| SEIC | 30.30% | $10.24B | +37.78% | 1.16% |
| MXL | 30.25% | $1.22B | -18.18% | 0.00% |
| STM | 30.09% | $21.92B | -45.89% | 1.23% |
| EEFT | 29.15% | $4.44B | +16.88% | 0.00% |
| AVTR | 28.99% | $13.42B | -0.40% | 0.00% |
| USNA | 28.84% | $744.09M | -16.12% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NINE | -<0.01% | $49.99M | -42.44% | 0.00% |
| BCOV | 0.01% | $133.15M | +17.06% | 0.00% |
| OCX | 0.02% | $42.93M | -36.09% | 0.00% |
| TTE | 0.03% | $138.45B | -11.95% | 5.50% |
| REPX | 0.04% | $745.24M | +32.40% | 4.19% |
| RYI | 0.04% | $751.91M | -19.47% | 3.18% |
| CLDX | 0.04% | $1.66B | -10.82% | 0.00% |
| VTOL | 0.07% | $1.07B | +42.07% | 0.00% |
| VLTO | -0.07% | $25.72B | +43.80% | 0.34% |
| PBR | 0.08% | $52.88B | -8.22% | 5.68% |
| CLBK | 0.08% | $1.89B | +4.93% | 0.00% |
| PBT | -0.13% | $606.38M | -27.11% | 5.87% |
| WRAP | 0.14% | $62.86M | -49.45% | 0.00% |
| CCRN | -0.14% | $341.35M | -50.81% | 0.00% |
| TSLA | -0.16% | $1.11T | +43.45% | 0.00% |
| AROW | 0.16% | $546.36M | +34.05% | 4.19% |
| RYAM | -0.16% | $596.54M | +189.14% | 0.00% |
| TBRG | 0.17% | $244.47M | +52.66% | 0.00% |
| MBIN | 0.18% | $1.78B | +16.49% | 0.90% |
| CORZ | 0.22% | $4.60B | +3,201.26% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LTM | -37.53% | $8.51B | -100.00% | <0.01% |
| MRNS | -26.60% | $16.97M | -94.82% | 0.00% |
| POAI | -25.48% | $4.29M | -78.60% | 0.00% |
| NEUE | -21.32% | $40.93M | -34.13% | 0.00% |
| CREG | -19.46% | $6.14M | -35.78% | 0.00% |
| EDR | -18.55% | $9.01B | +19.26% | 0.82% |
| ATEX | -17.02% | $617.94M | +5.94% | 0.00% |
| RES | -16.91% | $1.26B | -20.54% | 2.74% |
| PLCE | -16.32% | $194.34M | -20.91% | 0.00% |
| FCNCA | -16.13% | $31.02B | +54.47% | 0.30% |
| SNY | -15.28% | $120.34B | +3.11% | 4.25% |
| PEGA | -15.06% | $7.36B | +65.88% | 0.14% |
| SLVM | -14.73% | $3.55B | +82.37% | 1.72% |
| RTX | -12.76% | $158.34B | +52.22% | 2.09% |
| SSSS | -12.72% | - | - | 0.00% |
| TCS | -12.50% | $14.81M | -84.46% | 0.00% |
| KDP | -12.41% | $42.76B | -1.22% | 2.77% |
| CASH | -12.38% | $1.97B | +58.93% | 0.25% |
| WU | -12.36% | $3.63B | -9.74% | 8.78% |
| ASPS | -12.14% | $22.36M | -80.26% | 0.00% |
ETF's related to WST
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| RSPH | 32.94% | $885.96M | 0.4% |
| DGRW | 31.55% | $14.87B | 0.28% |
| PINK | 31.40% | $161.15M | 0.5% |
| PFUT | 30.92% | $326.69M | 0.64% |
| CGGO | 30.63% | $4.67B | 0.47% |
| IYJ | 30.52% | $1.64B | 0.39% |
| BUFD | 30.27% | $1.05B | 0.95% |
| IYT | 30.16% | $728.33M | 0.39% |
| PNQI | 30.06% | $834.26M | 0.6% |
| FLQL | 29.87% | $1.46B | 0.29% |
| QUAL | 29.84% | $50.11B | 0.15% |
| RSPD | 29.05% | $298.43M | 0.4% |
| IYC | 29.03% | $1.22B | 0.39% |
| IHI | 28.83% | $4.91B | 0.4% |
| BETZ | 28.66% | $79.19M | 0.75% |
| FXH | 28.36% | $1.15B | 0.62% |
| KRMA | 28.14% | $644.51M | 0.43% |
| IYH | 28.08% | $3.19B | 0.39% |
| FHLC | 28.03% | $2.73B | 0.084% |
| FDIS | 27.83% | $1.93B | 0.084% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| DBB | 0.03% | $126.37M | 0.77% |
| BCI | -0.24% | $1.20B | 0.26% |
| XHLF | 0.25% | $874.27M | 0.03% |
| PREF | -0.28% | $999.92M | 0.55% |
| FLRN | -0.39% | $2.33B | 0.15% |
| GBIL | -0.43% | $5.60B | 0.12% |
| BCD | 0.55% | $245.02M | 0.3% |
| CPER | 0.55% | $159.52M | 0.97% |
| AGZ | -0.58% | $708.37M | 0.2% |
| XBIL | -0.60% | $637.70M | 0.15% |
| DBC | 0.74% | $1.39B | 0.87% |
| IVOL | -0.84% | $548.70M | 1.02% |
| VTIP | -0.89% | $11.71B | 0.04% |
| XONE | 1.02% | $548.88M | 0.03% |
| IBTE | 1.19% | $1.70B | 0.07% |
| PDBC | -1.38% | $4.40B | 0.59% |
| USCI | -1.40% | $185.47M | 1.07% |
| IBMM | -1.42% | $391.28M | 0.18% |
| GSG | -1.44% | $914.42M | 0.75% |
| BSCO | 1.50% | $2.35B | 0.1% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -17.11% | $195.31M | 0.85% |
| TPMN | -14.97% | $40.60M | 0.65% |
| BTAL | -14.22% | $388.04M | 1.43% |
| TAIL | -13.09% | $67.98M | 0.59% |
| BOXX | -12.86% | $4.43B | 0.1949% |
| USDU | -11.53% | $201.97M | 0.5% |
| TBIL | -10.86% | $4.38B | 0.15% |
| IBDP | -10.05% | $2.11B | 0.1% |
| UNG | -7.88% | $908.80M | 1.06% |
| ICSH | -7.77% | $5.57B | 0.08% |
| SGOV | -7.00% | $27.53B | 0.09% |
| DFNM | -6.86% | $1.40B | 0.17% |
| UUP | -6.65% | $309.25M | 0.77% |
| DBO | -6.59% | $217.57M | 0.77% |
| DBE | -6.45% | $50.13M | 0.77% |
| KCCA | -6.35% | $220.51M | 0.87% |
| PWZ | -6.34% | $697.36M | 0.28% |
| FLTR | -5.54% | $1.79B | 0.14% |
| SHYD | -5.43% | $311.50M | 0.35% |
| FMF | -5.28% | $244.61M | 0.95% |
News
Yahoo
WST continues to gain momentum due to its strength in the Pharma market unit. However, decline across its Generics and Biologics business units is concerning.
MarketWatch
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors
Yahoo
West Pharmaceutical Services(NYSE:WST) has recently showcased its robust financial health with a 15% year-over-year revenue increase, driven by strong demand across key segments and the integration of AI-driven solutions into its product portfolio. Despite facing challenges such as a decline in earnings growth and rising raw material costs, the company is strategically expanding its technology-driven offerings and enhancing its competitive position through targeted marketing campaigns. The...
Yahoo
We recently made a list of UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors. In this piece, we will look at where West Pharmaceutical Services, Inc. (NYSE:WST) ranks on the list of UBS’ bottom quant stocks. With November 2024 having settled in and the US presidential election in […]
SeekingAlpha
Stay up to date on dividend activity for Dividend Champions, Contenders, and Challengers with changes, ex-dividend dates, and pay dates.
MarketWatch
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.